Lupin Ltd has announced that the Company is setting up a Unit with an investment of Rs 400 million for the manufacture of Steroids and other formulations at the special Economic Zone at Indore.
The said project would be set-up under Lupin Pharmacare Ltd, a wholly owned subsidiary of the Company.
The stock closed the day at Rs.574, down by Rs.2.60 or 0.45%. The stock hit an intraday high of Rs.580.85 and low of Rs.570.15.
The total traded quantity was 12650 compared to 2 week average of 31314.